Article
GWAS of extended prescription analgesic use identifies genetic loci in chronic pain.
Nature communications - 28 May 2026
Harlow Charli E, Uzochukwu Emeka, Fernando Hazel A, Mordaunt Charles E, Hughey Jordan M, Eicher John D, Robinson Lara, Bowker Nicholas, Howe Laurence, Liu Jimmy, Cortes Adrian, Wilson Paul, Gungabissoon Usha, Benson Victoria S, Nash Anthony, Young Gareth, Addis Laura, Xu Chun-Fang, Webber Caleb, Davitte Jonathan, Cader M Zameel
Abstract excerpt
Pain-related conditions are the leading cause of disability worldwide. Existing GWAS for chronic pain have mainly focused on individual pain-related disorders, which may not optimally capture the phenotype. Here, we define chronic pain based on prescription analgesic use ( ≥ 90 days) in two large biobanks (UK Biobank and FinnGen). GWAS meta-analyses of 11 prescription-based pain phenotypes identify 140...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
